Risk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS)

PloS One
Isabel Aguilar-PalacioEliseo Guallar

Abstract

Benefits of cardiovascular disease (CVD) risk factors control are well known, but goals achievement remains low. The objective of this study is to evaluate the prevalence of CVD risk factors among men ina worker's cohort with no previous CVD, to study control variations across time and the factors associated with poor control. To this end, we conducted a cohort reexamination (2010-2014) within the context of the Aragon Workers Health Study (AWHS). Data from working characteristics, analytical values and pharmacological prescription were included in the analysis. Prevalences of risk factor diagnosis and control were calculated, as well as factors associated with poor control. The prevalence of CVD risk factors was high. In 2014dyslipidaemia was the most prevalent (85.2%) followed by Hypertension (HT) (42.0%). People under treatment increased for the period analysed (p<0.001). The proportion of people treated varied from 72.2% in Diabetes Mellitus to 31.1% in dyslipidaemia in 2014. 46.2% of the workers with HT were controlled, decreasing to 21.9% in Diabetes and 11.0% in dyslipidaemia (2014). Working in a turn different to central shift was associated with poor control, especially for those working at night with HT (Odds Ratio in...Continue Reading

References

Jun 9, 1999·Scandinavian Journal of Work, Environment & Health·H Bøggild, A Knutsson
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Mar 29, 2005·Diabetes Care·Robert RatnerUNKNOWN Diabetes Prevention Program Research Group
Jan 12, 2007·British Journal of Clinical Pharmacology·Marie-Hélène BouchardSylvie Perreault
Apr 2, 2008·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Gaston GodinMarc Germain
Apr 20, 2011·European Journal of Preventive Cardiology·Jean DallongevilleUNKNOWN EURIKA Investigators
Jun 21, 2012·BMC Cardiovascular Disorders·José A CasasnovasValentín Fuster
Jul 4, 2012·The American Journal of Medicine·Sayed H NaderiDavid S Wald
Jul 28, 2012·BMJ : British Medical Journal·Manav V VyasDaniel G Hackam
Aug 3, 2013·European Heart Journal·Rajiv ChowdhuryOscar H Franco
Jul 2, 2014·Scandinavian Journal of Work, Environment & Health·Sarah E Neil-SztramkoCarolyn C Gotay
Aug 27, 2015·European Heart Journal·Nick TownsendMike Rayner
Nov 10, 2015·The New England Journal of Medicine·UNKNOWN SPRINT Research GroupWalter T Ambrosius
Jan 27, 2017·BMC Health Services Research·Annie QuickKate E Pickett

❮ Previous
Next ❯

Citations

Mar 22, 2020·Medicina·Gediminas UrbonasKarolis Vencevičius
Sep 30, 2020·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·J S RosalesS F Ameriso
Oct 24, 2020·International Journal of Environmental Research and Public Health·Isabel Aguilar-PalacioSara Malo
Dec 3, 2020·Journal of Clinical Medicine·Armando Chaure-PardosIsabel Aguilar-Palacio
Oct 17, 2020·Molecular Biology Reports·Thaysa Walléria de Aragão SantosDanyelly Bruneska Gondim Martins

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Related Papers

BMC Cardiovascular Disorders
José A CasasnovasValentin Fuster
Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis
Juan Pedro-BotetJuana A Flores-Le Roux
Diabetes, Obesity & Metabolism
P CullenG Assmann
© 2022 Meta ULC. All rights reserved